Viksnins Harris Padys Malen LLP
Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators
The disclosure relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): wherein L1, L2, A, B, R1, R2, R3, and R4 are described herein.
ARDELYX, INC.
A C A
A61P C07D A61P
inventional inventional inventional
Helene Lily Rakesh Jason Gustaf Jianhua Jeremy
Baribault Hu Jain Lewis Chao Caldwell